pyrrolomycin d has been researched along with nxl 104 in 1 studies
Studies (pyrrolomycin d) | Trials (pyrrolomycin d) | Recent Studies (post-2010) (pyrrolomycin d) | Studies (nxl 104) | Trials (nxl 104) | Recent Studies (post-2010) (nxl 104) |
---|---|---|---|---|---|
6 | 0 | 2 | 7 | 0 | 5 |
Protein | Taxonomy | pyrrolomycin d (IC50) | nxl 104 (IC50) |
---|---|---|---|
Peptidoglycan D,D-transpeptidase MrdA | Escherichia coli K-12 | 0.59 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barraja, P; Carbone, A; Cascioferro, S; Cirrincione, G; Diana, P; Montalbano, A; Parrino, B; Schillaci, D; Spanò, V | 1 |
1 other study(ies) available for pyrrolomycin d and nxl 104
Article | Year |
---|---|
Pharmaceutical Approaches to Target Antibiotic Resistance Mechanisms.
Topics: Azabicyclo Compounds; beta-Lactamase Inhibitors; Drug Resistance, Microbial; Enterobacteriaceae Infections; Humans; Imipenem; Pseudomonas Infections | 2017 |